Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Switching From Natalizumab to Fingolimod in Multiple Sclerosis: A French Prospective Study.
Pathogenesis of multiple sclerosis via environmental and genetic dysregulation of N-glycosylation.
Magnetization transfer imaging in multiple sclerosis treated with alemtuzumab.
Isolated trigeminal nerve palsy with motor involvement as a presenting manifestation of multiple sclerosis in an equatorial region - a case report.
Regional Cervical Cord Atrophy and Disability in Multiple Sclerosis: A Voxel-based Analysis.
Neuroprotective effects of riluzole in neurotrauma models: a review.
Cytokines and Disability in Interferon-β-1b Treated and Untreated Women with Multiple Sclerosis.
European medicines agency's committee for medicinal products for human use issues positive opinion on marketing authorisation application for Fampyra
Cytokine profile in relapsing‑remitting multiple sclerosis patients and the association between progression and activity of the disease.
Monosymptomatic clinically isolated syndrome with sudden sensorineural hearing loss: case report and critical review of the literature.
Laquinimod Halted MS Disability But Not Relapses
Management of children with multiple sclerosis.
Association Between Multiple Sclerosis and Erectile Dysfunction: A Nationwide Case-Control Study.
Review of MR elastography applications and recent developments.
Association of NOD1 and NOD2 polymorphisms with Guillain-Barré syndrome in Northern Indian population.
Impact of Cigarette Smoking on Conversion from Clinically Isolated Syndrome to Clinically Definite Multiple Sclerosis.
Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patients.
Repeated treatment with high dose cyclophosphamide for severe autoimmune diseases.
Substance Name: Dronabinol
Alemtuzumab (Lemtrada) - NICE says yes in final draft guidance
No association between chronic cerebrospinal venous insufficiency and pediatric-onset multiple sclerosis.
Differential diagnosis for cervical spondylotic myelopathy: literature review.
Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells.
Neuromyelitis optica presenting with relapses under treatment with natalizumab: a case report.
Changes in Cognitive Processing Speed, Mood, and Fatigue in an Observational Study of Persons With Multiple Sclerosis Treated With Dalfampridine-ER.
Pages
« first
‹ previous
…
167
168
169
170
171
172
173
174
175
…
next ›
last »